| Note | Vital | Class | Assessment | Draft | Date |
|---|---|---|---|---|---|
| Cellular senescence | 1 | B | This level-1 vital article is rated B-class. | 2026-10-13 | |
| Peto's paradox | 1 | B | This level-1 vital article is rated B-class. | 2026-10-13 | |
| Anti-frontrunner dynamics | 1 | C | This level-1 vital article is rated C-class. | 2026-11-04 | |
| Conflict between development and tumor suppression | 1 | C | This level-1 vital article is rated C-class. | 2026-11-07 | |
| Clonal evolution | 1 | C | This level-1 vital article is rated C-class. | 2026-08-26 | |
| De-Darwinization | 1 | C | This level-1 vital article is rated C-class. | 2025-09-20 | |
| Evolutionary transitions in individuality | 1 | C | This level-1 vital article is rated C-class. | 2026-08-26 | |
| Multicellular cooperation | 1 | C | This level-1 vital article is rated C-class. | 2026-08-26 | |
| Tumor Suppressor Theory of Aging | 1 | C | This level-1 vital article is rated C-class. | 2025-08-10 | |
| Mortality rate models | 2 | B | This level-2 vital article is rated B-class. | 2026-10-11 | |
| Mosaic vs regulative development spectrum | 2 | B | This level-2 vital article is rated B-class. | 2026-09-13 | |
| Quiescence depth | 2 | B | This level-2 vital article is rated B-class. | 2026-11-11 | |
| Antagonistic pleiotropy | 2 | B | This level-2 vital article is rated B-class. | 2026-10-13 | |
| Selection shadow | 2 | B | This level-2 vital article is rated B-class. | 2026-10-13 | |
| Senolytics | 2 | B | This level-2 vital article is rated B-class. | 2026-10-14 | |
| Telomeres | 2 | B | This level-2 vital article is rated B-class. | 2026-10-13 | |
| Weismann Barrier | 2 | B | This level-2 vital article is rated B-class. | 2026-08-08 | |
| Cell competition | 2 | C | This level-2 vital article is rated C-class. | 2026-11-13 | |
| Four eras of aging research | 2 | C | This level-2 vital article is rated C-class. | 2026-06-26 | |
| Pluripotency silencing | 2 | C | This level-2 vital article is rated C-class. | 2026-11-01 | |
| Terminal selectors | 2 | C | This level-2 vital article is rated C-class. | 2026-10-31 | |
| Types of tumor suppressor genes | 2 | C | This level-2 vital article is rated C-class. | 2025-12-09 | |
| Adaptive oncogenesis | 2 | C | This level-2 vital article is rated C-class. | 2026-08-26 | |
| Apoptosis | 2 | C | This level-2 vital article is rated C-class. | 2026-08-26 | |
| Baker INK-ATTAC experiment | 2 | C | This level-2 vital article is rated C-class. | 2026-09-12 | |
| Cancer ecology | 2 | C | This level-2 vital article is rated C-class. | 2026-08-26 | |
| CTVT - Canine Transmissible Venereal Tumor | 2 | C | This level-2 vital article is rated C-class. | 2025-08-10 | |
| Death Pact | 2 | C | This level-2 vital article is rated C-class. | 2025-08-10 | |
| Hayflick–Moorhead experiment | 2 | C | This level-2 vital article is rated C-class. | 2026-09-12 | |
| Multilevel selection | 2 | C | This level-2 vital article is rated C-class. | 2026-08-26 | |
| How malignant cells evade host coordination systems | 2 | C | This level-2 vital article is rated C-class. | 2025-08-10 | |
| Senescence-associated secretory phenotype (SASP) | 2 | C | This level-2 vital article is rated C-class. | 2026-09-12 | |
| Serrano–Lowe oncogene-induced senescence experiment | 2 | C | This level-2 vital article is rated C-class. | 2026-09-12 | |
| Takahashi–Yamanaka reprogramming experiment | 2 | C | This level-2 vital article is rated C-class. | 2026-09-12 | |
| Flower (Drosophila) | 2 | Start | This level-2 vital article is rated Start-class. | 2026-08-25 | |
| Immune Surveillance | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-10 | |
| KRAS | 2 | Start | This level-2 vital article is rated Start-class. | 2026-08-25 | |
| MTOR | 2 | Start | This level-2 vital article is rated Start-class. | 2026-08-25 | |
| MYC | 2 | Start | This level-2 vital article is rated Start-class. | 2026-08-25 | |
| NOTCH1 (NOTCH1) | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-21 | |
| p16INK4a (CDKN2A) | 2 | Start | This level-2 vital article is rated Start-class. | 2026-08-25 | |
| p21 (CDKN1A) | 2 | Start | This level-2 vital article is rated Start-class. | 2026-08-25 | |
| p53 (TP53) | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-21 | |
| Principal-Agent Problem | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-10 | |
| Rb (RB1) | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-21 | |
| Replicative Credit | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-10 | |
| Telomerase (TERT) | 2 | Start | This level-2 vital article is rated Start-class. | 2025-08-21 | |
| Empirical constraints on longevity models | 2 | Stub | This level-2 vital article is rated Stub-class. | 2026-10-16 | |
| Indeterminate growth | 3 | B | This level-3 vital article is rated B-class. | 2025-09-05 | |
| Critical-point model of ageing | 3 | B | This level-3 vital article is rated B-class. | 2026-10-14 | |
| Disposable soma theory | 3 | B | This level-3 vital article is rated B-class. | 2026-10-13 | |
| Reliability theory of ageing | 3 | B | This level-3 vital article is rated B-class. | 2026-10-14 | |
| Saturating-removal model of senescence | 3 | B | This level-3 vital article is rated B-class. | 2026-10-14 | |
| Strehler–Mildvan theory | 3 | B | This level-3 vital article is rated B-class. | 2026-10-14 | |
| Atavistic Theory of Cancer | 3 | C | This level-3 vital article is rated C-class. | 2025-08-10 | |
| Lewontin's conditions | 3 | C | This level-3 vital article is rated C-class. | 2025-09-20 | |
| Senescence and quiescence control loops | 3 | C | This level-3 vital article is rated C-class. | 2026-05-04 | |
| Adaptive therapy | 3 | C | This level-3 vital article is rated C-class. | 2026-08-26 | |
| Evolution of cooperation | 3 | C | This level-3 vital article is rated C-class. | 2026-08-26 | |
| Hallmarks of aging | 3 | C | This level-3 vital article is rated C-class. | 2026-09-12 | |
| Kenyon daf-2 experiment | 3 | C | This level-3 vital article is rated C-class. | 2026-09-12 | |
| Red Queen hypothesis | 3 | C | This level-3 vital article is rated C-class. | 2026-08-26 | |
| IMR90 ER RAS model | 3 | Start | This level-3 vital article is rated Start-class. | 2026-07-18 | |
| Tomasetti–Vogelstein model | 3 | Start | This level-3 vital article is rated Start-class. | 2025-11-09 | |
| AKT1 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| p14ARF | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Athena Aktipis | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| ATM | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| ATR | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| BAX | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| BCL-2 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| BCL-xL (BCL2L1) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| β-Catenin (CTNNB1) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| BRAF | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Carlo Maley | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| CTLA-4 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Devil Facial Tumor Disease (DFTD) | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-10 | |
| DNMT1 | 3 | Start | This level-3 vital article is rated Start-class. | 2025-10-05 | |
| E2F1 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| EGFR (ERBB1) | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-21 | |
| Eörs Szathmáry | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Eutely | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-20 | |
| FAS (CD95) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| FOXO3 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| George C. Williams | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| HeLa Cells | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-10 | |
| HLA-A | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| IGF-1 | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-21 | |
| IL-6 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| IL-8 (CXCL8) | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-21 | |
| James DeGregori | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| John Maynard Smith | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Judith Campisi | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Leo Buss | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Martin Nowak | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| MDM2 | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Mel Greaves | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Michael Levin | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Mina Bissell | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| PD-1 (PDCD1) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| PD-L1 (CD274) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Peter Nowell | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| PIK3CA (PI3Kα) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Richard Michod | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Robert Gatenby | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| SCANDAL Hypothesis | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-10 | |
| TAZ (WWTR1) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| TGFB1 (TGF-β1) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| TNF (TNF) | 3 | Start | This level-3 vital article is rated Start-class. | 2025-08-21 | |
| W. D. Hamilton | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| WNT3A | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| YAP1 (YAP) | 3 | Start | This level-3 vital article is rated Start-class. | 2026-08-25 | |
| Armitage–Doll model | 3 | Stub | This level-3 vital article is rated Stub-class. | 2025-11-09 | |
| Non-technical language in longevity | 3 | Stub | This level-3 vital article is rated Stub-class. | 2026-11-04 | |
| Classical embryology observations and their mechanisms | 4 | C | This level-4 vital article is rated C-class. | 2026-10-26 | |
| Self-Fertilization | 4 | C | This level-4 vital article is rated C-class. | 2025-08-10 | |
| Tissue signalling archetypes | 4 | C | This level-4 vital article is rated C-class. | 2026-11-02 | |
| Bathtub Dynamics | 4 | Start | This level-4 vital article is rated Start-class. | 2026-10-31 | |
| Goldbeter–Koshland module | 4 | Start | This level-4 vital article is rated Start-class. | 2026-06-21 | |
| Hopf bifurcation | 4 | Start | This level-4 vital article is rated Start-class. | 2026-06-21 | |
| Huang-Ferrell model | 4 | Start | This level-4 vital article is rated Start-class. | 2026-06-21 | |
| Novak–Tyson model | 4 | Start | This level-4 vital article is rated Start-class. | 2026-06-21 | |
| Taxonomy of non-mechanistic and causal models in biology | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-17 | |
| AKT2 (AKT2) | 4 | Start | This level-4 vital article is rated Start-class. | 2025-08-21 | |
| APAF1 | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| BAK1 (BAK) | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| Bioelectricity | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-26 | |
| Caspase-3 (CASP3) | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| David Sloan Wilson | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| EGF | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| IL-10 | 4 | Start | This level-4 vital article is rated Start-class. | 2025-08-21 | |
| Insulin | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| JAK2 | 4 | Start | This level-4 vital article is rated Start-class. | 2025-10-05 | |
| LMNA | 4 | Start | This level-4 vital article is rated Start-class. | 2025-10-05 | |
| MEK1 (MAP2K1) | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| MCL1 (MCL-1) | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| MMP9 | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| NFE2L2 (NRF2) | 4 | Start | This level-4 vital article is rated Start-class. | 2025-09-02 | |
| OGG1 | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| PRKAA1 (AMPKα1) | 4 | Start | This level-4 vital article is rated Start-class. | 2025-09-02 | |
| SHH (Sonic Hedgehog) | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| SIRT1 | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| VEGFA (VEGF) | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| XIAP | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| ZEB1 | 4 | Start | This level-4 vital article is rated Start-class. | 2026-08-25 | |
| Cell lineage recorders | 4 | Stub | This level-4 vital article is rated Stub-class. | 2026-08-07 | |
| Glossary | 4 | List | This level-4 vital article is rated List-class. | 2025-09-18 | |
| Tier List cell lines | 4 | List | This level-4 vital article is rated List-class. | 2026-10-21 | |
| Anti-frontrunner games | 5 | C | This level-5 vital article is rated C-class. | 2026-11-04 | |
| Flash-in-the-pan wet lab methods | 5 | C | This level-5 vital article is rated C-class. | 2026-10-22 | |
| FGA (Fibrinogen α) | 5 | Start | This level-5 vital article is rated Start-class. | 2026-08-25 | |
| GAPDH | 5 | Start | This level-5 vital article is rated Start-class. | 2026-08-25 | |
| QSOX1 | 5 | Start | This level-5 vital article is rated Start-class. | 2025-10-05 | |
| Research Gaps — Cnidarian Longevity & Rejuvenation | 5 | Start | This level-5 vital article is rated Start-class. | 2025-08-19 | |
| UBE3A | 5 | Start | This level-5 vital article is rated Start-class. | 2026-08-25 | |
| Labs | 5 | List | This level-5 vital article is rated List-class. | 2026-06-08 | |
| Tutorial: Iconoplasm API for third-party developers | — | NA | Rated NA-class. | 2026-06-23 | |
| Longevity Research Wiki | — | NA | Rated NA-class. | 2025-08-10 |
| Vital | Class | Note | Assessment | Draft |
|---|---|---|---|---|
| 1 | C | Anti-frontrunner dynamics | This level-1 vital article is rated C-class. | |
| 1 | C | Conflict between development and tumor suppression | This level-1 vital article is rated C-class. | |
| 1 | C | Clonal evolution | This level-1 vital article is rated C-class. | |
| 1 | C | De-Darwinization | This level-1 vital article is rated C-class. | |
| 1 | C | Evolutionary transitions in individuality | This level-1 vital article is rated C-class. | |
| 1 | C | Multicellular cooperation | This level-1 vital article is rated C-class. | |
| 1 | C | Tumor Suppressor Theory of Aging | This level-1 vital article is rated C-class. | |
| 1 | B | Cellular senescence | This level-1 vital article is rated B-class. | |
| 1 | B | Peto's paradox | This level-1 vital article is rated B-class. | |
| 2 | Stub | Empirical constraints on longevity models | This level-2 vital article is rated Stub-class. | |
| 2 | Start | Flower (Drosophila) | This level-2 vital article is rated Start-class. | |
| 2 | Start | Immune Surveillance | This level-2 vital article is rated Start-class. | |
| 2 | Start | KRAS | This level-2 vital article is rated Start-class. | |
| 2 | Start | MTOR | This level-2 vital article is rated Start-class. | |
| 2 | Start | MYC | This level-2 vital article is rated Start-class. | |
| 2 | Start | NOTCH1 (NOTCH1) | This level-2 vital article is rated Start-class. | |
| 2 | Start | p16INK4a (CDKN2A) | This level-2 vital article is rated Start-class. | |
| 2 | Start | p21 (CDKN1A) | This level-2 vital article is rated Start-class. | |
| 2 | Start | p53 (TP53) | This level-2 vital article is rated Start-class. | |
| 2 | Start | Principal-Agent Problem | This level-2 vital article is rated Start-class. | |
| 2 | Start | Rb (RB1) | This level-2 vital article is rated Start-class. | |
| 2 | Start | Replicative Credit | This level-2 vital article is rated Start-class. | |
| 2 | Start | Telomerase (TERT) | This level-2 vital article is rated Start-class. | |
| 2 | C | Cell competition | This level-2 vital article is rated C-class. | |
| 2 | C | Four eras of aging research | This level-2 vital article is rated C-class. | |
| 2 | C | Pluripotency silencing | This level-2 vital article is rated C-class. | |
| 2 | C | Terminal selectors | This level-2 vital article is rated C-class. | |
| 2 | C | Types of tumor suppressor genes | This level-2 vital article is rated C-class. | |
| 2 | C | Adaptive oncogenesis | This level-2 vital article is rated C-class. | |
| 2 | C | Apoptosis | This level-2 vital article is rated C-class. | |
| 2 | C | Baker INK-ATTAC experiment | This level-2 vital article is rated C-class. | |
| 2 | C | Cancer ecology | This level-2 vital article is rated C-class. | |
| 2 | C | CTVT - Canine Transmissible Venereal Tumor | This level-2 vital article is rated C-class. | |
| 2 | C | Death Pact | This level-2 vital article is rated C-class. | |
| 2 | C | Hayflick–Moorhead experiment | This level-2 vital article is rated C-class. | |
| 2 | C | Multilevel selection | This level-2 vital article is rated C-class. | |
| 2 | C | How malignant cells evade host coordination systems | This level-2 vital article is rated C-class. | |
| 2 | C | Senescence-associated secretory phenotype (SASP) | This level-2 vital article is rated C-class. | |
| 2 | C | Serrano–Lowe oncogene-induced senescence experiment | This level-2 vital article is rated C-class. | |
| 2 | C | Takahashi–Yamanaka reprogramming experiment | This level-2 vital article is rated C-class. | |
| 2 | B | Mortality rate models | This level-2 vital article is rated B-class. | |
| 2 | B | Mosaic vs regulative development spectrum | This level-2 vital article is rated B-class. | |
| 2 | B | Quiescence depth | This level-2 vital article is rated B-class. | |
| 2 | B | Antagonistic pleiotropy | This level-2 vital article is rated B-class. | |
| 2 | B | Selection shadow | This level-2 vital article is rated B-class. | |
| 2 | B | Senolytics | This level-2 vital article is rated B-class. | |
| 2 | B | Telomeres | This level-2 vital article is rated B-class. | |
| 2 | B | Weismann Barrier | This level-2 vital article is rated B-class. |
| Vital | Class | Note | Assessment | Draft | Updated |
|---|---|---|---|---|---|
| 1 | B | Cellular senescence | This level-1 vital article is rated B-class. | 31d ago | |
| 1 | B | Peto's paradox | This level-1 vital article is rated B-class. | 31d ago | |
| 1 | C | Anti-frontrunner dynamics | This level-1 vital article is rated C-class. | 9d ago | |
| 1 | C | Clonal evolution | This level-1 vital article is rated C-class. | 79d ago | |
| 1 | C | Evolutionary transitions in individuality | This level-1 vital article is rated C-class. | 79d ago | |
| 1 | C | Multicellular cooperation | This level-1 vital article is rated C-class. | 79d ago | |
| 1 | C | Tumor Suppressor Theory of Aging | This level-1 vital article is rated C-class. | 460d ago | |
| 1 | C | De-Darwinization | This level-1 vital article is rated C-class. | 419d ago | |
| 1 | C | Conflict between development and tumor suppression | This level-1 vital article is rated C-class. | 6d ago | |
| 2 | B | Senolytics | This level-2 vital article is rated B-class. | 30d ago | |
| 2 | B | Quiescence depth | This level-2 vital article is rated B-class. | 2d ago | |
| 2 | B | Antagonistic pleiotropy | This level-2 vital article is rated B-class. | 31d ago | |
| 2 | B | Selection shadow | This level-2 vital article is rated B-class. | 31d ago | |
| 2 | B | Telomeres | This level-2 vital article is rated B-class. | 31d ago | |
| 2 | B | Mosaic vs regulative development spectrum | This level-2 vital article is rated B-class. | 61d ago | |
| 2 | B | Mortality rate models | This level-2 vital article is rated B-class. | 33d ago | |
| 2 | B | Weismann Barrier | This level-2 vital article is rated B-class. | 97d ago | |
| 2 | C | Adaptive oncogenesis | This level-2 vital article is rated C-class. | 79d ago | |
| 2 | C | Apoptosis | This level-2 vital article is rated C-class. | 79d ago | |
| 2 | C | Cancer ecology | This level-2 vital article is rated C-class. | 79d ago | |
| 2 | C | Multilevel selection | This level-2 vital article is rated C-class. | 79d ago | |
| 2 | C | Types of tumor suppressor genes | This level-2 vital article is rated C-class. | 339d ago | |
| 2 | C | Pluripotency silencing | This level-2 vital article is rated C-class. | 12d ago | |
| 2 | C | CTVT - Canine Transmissible Venereal Tumor | This level-2 vital article is rated C-class. | 460d ago | |
| 2 | C | Death Pact | This level-2 vital article is rated C-class. | 460d ago | |
| 2 | C | How malignant cells evade host coordination systems | This level-2 vital article is rated C-class. | 460d ago | |
| 2 | C | Baker INK-ATTAC experiment | This level-2 vital article is rated C-class. | 62d ago | |
| 2 | C | Hayflick–Moorhead experiment | This level-2 vital article is rated C-class. | 62d ago | |
| 2 | C | Senescence-associated secretory phenotype (SASP) | This level-2 vital article is rated C-class. | 62d ago | |
| 2 | C | Serrano–Lowe oncogene-induced senescence experiment | This level-2 vital article is rated C-class. | 62d ago | |
| 2 | C | Takahashi–Yamanaka reprogramming experiment | This level-2 vital article is rated C-class. | 62d ago | |
| 2 | C | Terminal selectors | This level-2 vital article is rated C-class. | 13d ago | |
| 2 | C | Cell competition | This level-2 vital article is rated C-class. | 9h ago | |
| 2 | C | Four eras of aging research | This level-2 vital article is rated C-class. | 140d ago | |
| 2 | Start | Flower (Drosophila) | This level-2 vital article is rated Start-class. | 80d ago | |
| 2 | Start | KRAS | This level-2 vital article is rated Start-class. | 80d ago | |
| 2 | Start | MTOR | This level-2 vital article is rated Start-class. | 80d ago | |
| 2 | Start | MYC | This level-2 vital article is rated Start-class. | 80d ago | |
| 2 | Start | p16INK4a (CDKN2A) | This level-2 vital article is rated Start-class. | 80d ago | |
| 2 | Start | p21 (CDKN1A) | This level-2 vital article is rated Start-class. | 80d ago | |
| 2 | Start | NOTCH1 (NOTCH1) | This level-2 vital article is rated Start-class. | 449d ago | |
| 2 | Start | p53 (TP53) | This level-2 vital article is rated Start-class. | 449d ago | |
| 2 | Start | Rb (RB1) | This level-2 vital article is rated Start-class. | 449d ago | |
| 2 | Start | Telomerase (TERT) | This level-2 vital article is rated Start-class. | 449d ago | |
| 2 | Start | Immune Surveillance | This level-2 vital article is rated Start-class. | 460d ago | |
| 2 | Start | Principal-Agent Problem | This level-2 vital article is rated Start-class. | 460d ago | |
| 2 | Start | Replicative Credit | This level-2 vital article is rated Start-class. | 460d ago | |
| 2 | Stub | Empirical constraints on longevity models | This level-2 vital article is rated Stub-class. | 28d ago | |
| 3 | B | Critical-point model of ageing | This level-3 vital article is rated B-class. | 30d ago | |
| 3 | B | Reliability theory of ageing | This level-3 vital article is rated B-class. | 30d ago | |
| 3 | B | Saturating-removal model of senescence | This level-3 vital article is rated B-class. | 30d ago | |
| 3 | B | Strehler–Mildvan theory | This level-3 vital article is rated B-class. | 30d ago | |
| 3 | B | Disposable soma theory | This level-3 vital article is rated B-class. | 31d ago | |
| 3 | B | Indeterminate growth | This level-3 vital article is rated B-class. | 434d ago | |
| 3 | C | Adaptive therapy | This level-3 vital article is rated C-class. | 79d ago | |
| 3 | C | Evolution of cooperation | This level-3 vital article is rated C-class. | 79d ago | |
| 3 | C | Red Queen hypothesis | This level-3 vital article is rated C-class. | 79d ago | |
| 3 | C | Atavistic Theory of Cancer | This level-3 vital article is rated C-class. | 460d ago | |
| 3 | C | Lewontin's conditions | This level-3 vital article is rated C-class. | 419d ago | |
| 3 | C | Hallmarks of aging | This level-3 vital article is rated C-class. | 62d ago | |
| 3 | C | Kenyon daf-2 experiment | This level-3 vital article is rated C-class. | 62d ago | |
| 3 | C | Senescence and quiescence control loops | This level-3 vital article is rated C-class. | 193d ago | |
| 3 | Start | Eutely | This level-3 vital article is rated Start-class. | 450d ago | |
| 3 | Start | AKT1 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | p14ARF | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Athena Aktipis | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | ATM | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | ATR | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | BAX | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | BCL-2 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | BCL-xL (BCL2L1) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | β-Catenin (CTNNB1) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | BRAF | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Carlo Maley | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | CTLA-4 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | E2F1 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Eörs Szathmáry | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | FAS (CD95) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | FOXO3 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | George C. Williams | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | HLA-A | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | IL-6 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | James DeGregori | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | John Maynard Smith | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Judith Campisi | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Leo Buss | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Martin Nowak | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | MDM2 | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Mel Greaves | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Michael Levin | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Mina Bissell | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | PD-1 (PDCD1) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | PD-L1 (CD274) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Peter Nowell | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | PIK3CA (PI3Kα) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Richard Michod | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | Robert Gatenby | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | TAZ (WWTR1) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | TGFB1 (TGF-β1) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | W. D. Hamilton | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | WNT3A | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | YAP1 (YAP) | This level-3 vital article is rated Start-class. | 80d ago | |
| 3 | Start | EGFR (ERBB1) | This level-3 vital article is rated Start-class. | 449d ago | |
| 3 | Start | IGF-1 | This level-3 vital article is rated Start-class. | 449d ago | |
| 3 | Start | IL-8 (CXCL8) | This level-3 vital article is rated Start-class. | 449d ago | |
| 3 | Start | TNF (TNF) | This level-3 vital article is rated Start-class. | 449d ago | |
| 3 | Start | DNMT1 | This level-3 vital article is rated Start-class. | 404d ago | |
| 3 | Start | Tomasetti–Vogelstein model | This level-3 vital article is rated Start-class. | 369d ago | |
| 3 | Start | Devil Facial Tumor Disease (DFTD) | This level-3 vital article is rated Start-class. | 460d ago | |
| 3 | Start | HeLa Cells | This level-3 vital article is rated Start-class. | 460d ago | |
| 3 | Start | SCANDAL Hypothesis | This level-3 vital article is rated Start-class. | 460d ago | |
| 3 | Start | IMR90 ER RAS model | This level-3 vital article is rated Start-class. | 118d ago | |
| 3 | Stub | Non-technical language in longevity | This level-3 vital article is rated Stub-class. | 9d ago | |
| 3 | Stub | Armitage–Doll model | This level-3 vital article is rated Stub-class. | 369d ago | |
| 4 | C | Self-Fertilization | This level-4 vital article is rated C-class. | 460d ago | |
| 4 | C | Classical embryology observations and their mechanisms | This level-4 vital article is rated C-class. | 18d ago | |
| 4 | C | Tissue signalling archetypes | This level-4 vital article is rated C-class. | 11d ago | |
| 4 | Start | Bioelectricity | This level-4 vital article is rated Start-class. | 79d ago | |
| 4 | Start | NFE2L2 (NRF2) | This level-4 vital article is rated Start-class. | 437d ago | |
| 4 | Start | PRKAA1 (AMPKα1) | This level-4 vital article is rated Start-class. | 437d ago | |
| 4 | Start | APAF1 | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | BAK1 (BAK) | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | Caspase-3 (CASP3) | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | David Sloan Wilson | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | EGF | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | Insulin | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | MEK1 (MAP2K1) | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | MCL1 (MCL-1) | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | MMP9 | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | OGG1 | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | SHH (Sonic Hedgehog) | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | SIRT1 | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | VEGFA (VEGF) | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | XIAP | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | ZEB1 | This level-4 vital article is rated Start-class. | 80d ago | |
| 4 | Start | AKT2 (AKT2) | This level-4 vital article is rated Start-class. | 449d ago | |
| 4 | Start | IL-10 | This level-4 vital article is rated Start-class. | 449d ago | |
| 4 | Start | JAK2 | This level-4 vital article is rated Start-class. | 404d ago | |
| 4 | Start | LMNA | This level-4 vital article is rated Start-class. | 404d ago | |
| 4 | Start | Goldbeter–Koshland module | This level-4 vital article is rated Start-class. | 145d ago | |
| 4 | Start | Hopf bifurcation | This level-4 vital article is rated Start-class. | 145d ago | |
| 4 | Start | Huang-Ferrell model | This level-4 vital article is rated Start-class. | 145d ago | |
| 4 | Start | Novak–Tyson model | This level-4 vital article is rated Start-class. | 145d ago | |
| 4 | Start | Bathtub Dynamics | This level-4 vital article is rated Start-class. | 13d ago | |
| 4 | Start | Taxonomy of non-mechanistic and causal models in biology | This level-4 vital article is rated Start-class. | 88d ago | |
| 4 | Stub | Cell lineage recorders | This level-4 vital article is rated Stub-class. | 98d ago | |
| 4 | List | Tier List cell lines | This level-4 vital article is rated List-class. | 23d ago | |
| 4 | List | Glossary | This level-4 vital article is rated List-class. | 421d ago | |
| 5 | C | Anti-frontrunner games | This level-5 vital article is rated C-class. | 9d ago | |
| 5 | C | Flash-in-the-pan wet lab methods | This level-5 vital article is rated C-class. | 22d ago | |
| 5 | Start | FGA (Fibrinogen α) | This level-5 vital article is rated Start-class. | 80d ago | |
| 5 | Start | GAPDH | This level-5 vital article is rated Start-class. | 80d ago | |
| 5 | Start | UBE3A | This level-5 vital article is rated Start-class. | 80d ago | |
| 5 | Start | Research Gaps — Cnidarian Longevity & Rejuvenation | This level-5 vital article is rated Start-class. | 451d ago | |
| 5 | Start | QSOX1 | This level-5 vital article is rated Start-class. | 404d ago | |
| 5 | List | Labs | This level-5 vital article is rated List-class. | 158d ago | |
| — | NA | Tutorial: Iconoplasm API for third-party developers | Rated NA-class. | 143d ago | |
| — | NA | Longevity Research Wiki | Rated NA-class. | 460d ago |